Learn more about making an appointment, referrals, and resources that are at your disposal.
The Abdominal Transplant and Hepatopancreaticobiliary Surgery Division provides comprehensive surgical care for patients experiencing conditions of the liver, pancreas, gallbladder, or bile ducts. Our team of highly skilled and compassionate specialists work together to determine the best treatment plan for you, offering a range of surgical options from traditional surgery to minimally invasive and robotic-assisted approaches, and including organ transplantation when needed.
Our care teams closely evaluate your condition before determining your treatment options, which could mean you may need other treatments like radiation or systemic treatment prior to surgery. Our surgeons’ expertise means we can successfully treat more patients with surgery. Our surgeons treat many liver and bile duct conditions, including:
Physicians from hepatology (the medical specialty focusing on the liver and nearby organs) and other specialties work together on your care. They deliver personalized diagnosis and treatment for problems affecting the liver and bile duct system. Learn more about our liver transplant and hepatology program. Highlights of our program include:
At AHN, we take pride in offering minimally invasive techniques when available and all-encompassing approaches when needed.
In some cases, laparoscopic or hand-assisted surgery can be used to perform a liver resection, or a removal of part of the liver. The surgeons will review your case and decide whether it may be possible, safe, and effective to perform your surgery in this way. It allows for smaller incisions and a more rapid recovery. We are now able to offer this type of surgery in approximately 50% of liver resection cases.Specific surgeries we do include robotic assisted:
Some patients require more complex surgical planning and are unable to undergo minimally invasive surgery. Often this means a patient will undergo:
Sometimes surgery is not the first and only option, and we work with specialists to give treatments before surgery. These treatments can include a combination of treatment techniques to help them on the road to liver surgery. Prior to undergoing removal of their liver cancer, another treatment modality may be used to help shrink the tumor or prepare the liver for surgery.
For example, up-front chemotherapy (called “neoadjuvant”) may be performed to prime the cancer for removal or decrease the size and number of tumors that have to be taken out with surgery.
If there are too many tumors to be safely removed with surgery alone, we frequently use a combined approach with radiation oncology and stereotactic body radiation therapy (SBRT). Liver SBRT is a rapidly emerging noninvasive technique that allows for precise delivery of high doses of radiation to the tumors. In the same patient, we can use surgery to remove some liver tumors and SBRT to treat the others. This allows us to offer aggressive surgical resection to patients with multiple tumors or tumors in an unfavorable location for removal.
In other cases, a technique called portal vein embolization (PVE) is used to grow the healthy side of the liver before surgery. This allows even patients with larger tumors to be considered as surgical candidates. A type of doctor called an interventional radiologist uses a catheter through the skin to limit the blood flow to the cancerous side of the liver. The side with the cancer then shrinks (atrophies) over three to four weeks, while the healthy side grows (hypertrophies). Surgery is then performed to remove the cancerous side and leave behind a safe amount of liver tissue for the body to function.
Another technique is called radioembolization (Y90), performed by the interventional radiology team that helps treat the tumor in addition to growing the opposite side of the liver to help with resection and or to get to transplant.
Thanks to this teamwork between specialties — and our aggressive technical approach — surgery is now an option for an increasing number of patients with cancer in the liver and bile ducts.
To find out whether you or a loved one may be eligible for these services, contact our office at 412-359-6738.
As with nearly every surgery, complications can happen with a hepatobiliary surgery. Your AHN team will be with you through the entire surgery and post-op to ensure all considerations are taken to aim for a complication-free experience. However, there are things that can happen, including:
AHN surgery specialists focused on hepatopancreaticobiliary treatment are highly trained, experienced, compassionate surgeons and health care professionals who see each patient as an individual with unique needs, and tailor treatment to meet those.
Surgeon
Surgeon
Surgeon
Surgeon
Surgeon
Call 412-359-6738 to schedule an appointment with our Abdominal Transplant and Hepatopancreaticobiliary Surgery Division.
At your appointment, you should expect to meet with a specialist who will discuss treatment options, outcomes, and expectations. This may include reviewing your prior imaging, lab results, and pathology results. Your case may also be discussed at our multidisciplinary tumor board to confirm the treatment plan and provide the opportunity for the best possible approach. We will also address any questions you or your supporters (family, friends, etc.) may have regarding your upcoming treatment.
Clinical trials offer eligible patients who volunteer to participate, new options for cancer treatment with novel uses of medications, radiation or surgical techniques with the goal to improve cancer treatment as a whole. You can discuss available active clinical trials with your doctor and determine your eligibility to participate.
Currently active transplant clinical trials at AHN include:
Clinical trials are studies that try to answer questions about new ways to treat cancer with medications, radiation, or surgical techniques. Previous trials have shown how new methods of treatment improve survival and quality of life and reduce the risk of cancer returning.
You participate in a clinical trial only if you volunteer to do so and meet criteria for inclusion in the study, and you can stop participating in a trial at any time.
The plan for the trial, called a protocol, explains what the trial will do and how the study will be done. Based on the questions the research is trying to answer, each clinical trial protocol outlines specific criteria necessary to be eligible to join the trial.
Federal rules help ensure that clinical trials are run in an ethical manner, with your rights and safety protected. It’s to ensure that you’re not put at increased risk by participating in the trial, and that the results of the study are accurate and meaningful.
There are two ways for medical professionals who are not a part of Allegheny Health Network, to refer their patients to an AHN specialist and request their first appointment. You can:
For more information about referring your patient to an AHN specialist, read the Independent Physician Referral FAQs.
Once your patient is receiving care from an AHN specialist, you can view their test results, see their treatment plan, follow their treatment progress, and collaborate with our team using the EpicCare® Link™ platform.
If you are new to EpicCare Link, or need to request your own EpicCare Link account, read: EpicCare Link for Patient Follow-up, for user instructions and new account request forms.
If you can’t access your patient's AHN test results through the EpicCare Link platform, your patient will need to complete and submit the correct AHN Medical Records Release form, based on their state of residency. Support your patient’s request by downloading the correct medical records release form for them:
EpicCare® is a registered trademark of Epic Systems Corporation and used with permission.
EpicCare® Link™ is a trademark of Epic Systems Corporation and used with permission.
Learn more about making an appointment, referrals, and resources that are at your disposal.